Article2000

Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder

Atul C. Pande · Mark H. Pollack · Jerri G. Crockatt · Martha Greiner · Guy Chouinard · R. Bruce Lydiard +3 more

279 citations0/0 files storedJournal of Clinical Psychopharmacology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Treatment of Major Depression Maternal Mental Health During Pregnancy and Postpartum

Abstract

A randomized, double-blind, placebo-controlled, parallel-group study was conducted to evaluate the efficacy and safety of gabapentin in relieving the symptoms of panic disorder. One hundred three patients were randomly assigned to receive double-blind treatment with either gabapentin (dosed flexibly between 600 and 3,600 mg/day) or placebo for 8 weeks. No overall drug/placebo difference was observed in scores on the Panic and Agoraphobia Scale (PAS) (p = 0.606). A post hoc analysis was used to evaluate the more severely ill patients as defined by the primary outcome measure (PAS score > or = 20). In this population, the gabapentin-treated patients showed significant improvement in the PAS change score (p = 0.04). In patients with a PAS score of 20 or greater, women showed a greater response than men regardless of treatment. Adverse events were consistent with the known side effect profile of gabapentin and included somnolence, headache, and dizziness. One patient experienced a serious adverse event during the study. No deaths were reported. The results of this study suggest that gabapentin may have anxiolytic effects in more severely ill patients with panic disorder.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 279 citations exist upstream.

References

1960A RATING SCALE FOR DEPRESSION 1994Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States 1959THE ASSESSMENT OF ANXIETY STATES BY RATING 1979Brief standard self-rating for phobic patients 1988Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial 1999Treatment of Social Phobia With Gabapentin 1998Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder 1995Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

Cited by

2007Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof‐of‐concept trial in physically injured patients 2018Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder 2002Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder 2007The Role of Anticonvulsant Drugs in Anxiety Disorders 2011

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.